Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">ICHOR Corporation: Color on Quarter (16.71)<ul><li>Cowen <strong>raises tgt to $22 from $20</strong>, stays at Outperform. The firm believes the cos still lack a ton of 2H:17 visibility and are taking a conservative tack, but ICHR wouldn't have invested the money to expand quarterly revenue capacity well into the low $200MMs (another ~50% from here!) if customers like LRCX weren't asking for it (even if timing is hard to determine). The firm notes the float here is still small, but the point here is that ICHR still has upside potential.</li><li>RBC <strong>raises tgt to $19 from $18</strong>, stays at Outperform. The firm believes that the <strong>key focus points</strong> through the year will be the degree to which ICHR can continue to gain market share in both gas and liquid delivery markets.</li><li>Needham reiterates Buy and <strong>raises its PT from $17 to $21</strong>. With high exposure to growing segments leveraging technology inflections in WFE and its success in winning at key customers, the firm believes ICHR will continue to outperform the industry.</li><li>Stifel maintain its Buy rating and <strong>raises its tgt to $20 from $17</strong>. While the company's results and outlook reflected the very favorable industry current trends, the firm believes the company continues to outperform the industry growth rates. The firm <strong>believes its strong position with its top two customers</strong> (Applied Materials and Lam Research), its increasing presence within them, and new market opportunities (in areas like fluid delivery and process areas like CMP) provide it with a <strong>strong tailwind for another above-average growth year in 2017.</strong></li></ul><p><em>ICHR shares are up ~4.5% at 17.5 in after hours trading.</em></p></td> </tr></table>"